Harrow Historical Financial Ratios
| HROW Stock | USD 42.06 0.84 1.96% |
Harrow Health is recently reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 4.93 or Days Sales Outstanding of 107 will help investors to properly organize and evaluate Harrow Health financial condition quickly.
Harrow |
About Harrow Financial Ratios Analysis
Harrow HealthFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Harrow Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Harrow financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Harrow Health history.
Harrow Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Harrow Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Harrow Health sales, a figure that is much harder to manipulate than other Harrow Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Harrow Health dividend as a percentage of Harrow Health stock price. Harrow Health dividend yield is a measure of Harrow Health stock productivity, which can be interpreted as interest rate earned on an Harrow Health investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Net Debt To E B I T D A
A leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA).Most ratios from Harrow Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Harrow Health current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.At this time, Harrow Health's Interest Coverage is fairly stable compared to the past year. Capex To Operating Cash Flow is likely to climb to 41.71 in 2024, whereas PTB Ratio is likely to drop 4.93 in 2024.
| 2023 | 2024 (projected) | Dividend Yield | 6.32E-4 | 6.0E-4 | Price To Sales Ratio | 2.81 | 2.67 |
Harrow Health fundamentals Correlations
Click cells to compare fundamentals
Harrow Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Harrow Health fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 3.85 | 3.63 | 3.19 | 4.58 | 2.81 | 2.67 | |
| Ptb Ratio | 7.11 | 6.54 | 20.48 | 14.88 | 5.19 | 4.93 | |
| Days Sales Outstanding | 14.33 | 19.88 | 22.75 | 26.32 | 102.3 | 107.41 | |
| Free Cash Flow Yield | (0.004502) | (0.0118) | (0.1) | (0.015) | (0.41) | (0.39) | |
| Operating Cash Flow Per Share | 0.0289 | 0.0375 | (0.0425) | 0.19 | 0.0621 | 0.12 | |
| Stock Based Compensation To Revenue | 0.0637 | 0.0395 | 0.0568 | 0.0793 | 0.09 | 0.12 | |
| Capex To Depreciation | 0.69 | 0.36 | 11.9 | 2.12 | 12.36 | 12.98 | |
| Pb Ratio | 7.11 | 6.54 | 20.48 | 14.88 | 5.19 | 4.93 | |
| Ev To Sales | 4.17 | 4.03 | 3.68 | 4.66 | 3.7 | 3.52 | |
| Free Cash Flow Per Share | (0.0637) | (0.035) | (0.0809) | (0.88) | (4.56) | (4.33) | |
| Roic | (0.25) | (0.0371) | (0.003438) | (0.0133) | 0.002333 | 0.002449 | |
| Inventory Turnover | 9.01 | 5.07 | 3.65 | 4.32 | 3.88 | 5.23 | |
| Net Income Per Share | (0.1) | (0.13) | (0.67) | (0.51) | (0.75) | (0.79) | |
| Days Of Inventory On Hand | 71.94 | 99.99 | 84.51 | 94.06 | 100.06 | 92.81 | |
| Payables Turnover | 2.26 | 3.97 | 3.52 | 3.94 | 1.85 | 2.24 | |
| Research And Ddevelopement To Revenue | 0.0407 | 0.0494 | 0.15 | 0.0344 | 0.0529 | 0.0502 | |
| Capex To Revenue | 0.0359 | 0.0203 | 0.39 | 0.0877 | 1.17 | 1.23 | |
| Pocfratio | 207.38 | (161.49) | 45.49 | 237.73 | 95.13 | 99.89 | |
| Interest Coverage | (0.2) | (0.73) | (0.0522) | (0.24) | 0.0272 | 0.0286 | |
| Capex To Operating Cash Flow | 1.93 | (0.9) | 5.61 | 4.56 | 39.73 | 41.71 | |
| Pfcf Ratio | (222.11) | (84.83) | (9.87) | (66.8) | (2.46) | (2.58) | |
| Days Payables Outstanding | 161.46 | 91.99 | 103.68 | 92.61 | 197.27 | 169.86 | |
| Income Quality | (7.6) | 0.32 | (0.28) | (0.12) | (0.16) | (0.15) | |
| Roe | (0.0935) | (0.13) | (1.6) | (0.52) | (0.35) | (0.36) | |
| Ev To Operating Cash Flow | 224.48 | (179.16) | 52.53 | 242.36 | 125.45 | 131.72 | |
| Pe Ratio | (76.01) | (51.96) | (12.84) | (28.77) | (14.96) | (15.71) | |
| Return On Tangible Assets | (0.0459) | (0.0619) | (0.22) | (0.11) | (0.16) | (0.17) | |
| Ev To Free Cash Flow | (240.42) | (94.11) | (11.39) | (68.1) | (3.24) | (3.4) | |
| Earnings Yield | (0.0132) | (0.0192) | (0.0779) | (0.0348) | (0.0668) | (0.0702) | |
| Intangibles To Total Assets | 0.0452 | 0.0395 | 0.18 | 0.17 | 0.52 | 0.55 | |
| Net Debt To E B I T D A | 11.29 | 5.57 | (3.53) | (2.47) | 11.97 | 12.57 | |
| Current Ratio | 2.99 | 3.72 | 6.24 | 6.35 | 2.82 | 2.68 | |
| Tangible Book Value Per Share | 0.98 | 0.95 | (0.24) | 0.0261 | (2.83) | (2.69) | |
| Receivables Turnover | 25.47 | 18.36 | 16.04 | 13.87 | 3.57 | 3.39 | |
| Graham Number | 1.59 | 1.77 | 2.53 | 3.38 | 6.03 | 5.73 | |
| Shareholders Equity Per Share | 1.09 | 1.05 | 0.42 | 0.99 | 2.16 | 2.13 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Harrow Stock Analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.